Prostate Cancer Clinical Trials in Atlanta

Showing 221-240 of 349 trials

A Survivorship Care Plan and Embedded Navigation Tool

NCT03424837

This is a parallel group, multisite prospective clinical study. The purpose of this study is to evaluate whether ASCENT enables patients to adhere to the survivorship guidelines and improves coordination of care to address patient needs.

Prostate Cancer

Duke University77 participantsStarted Jan 2019

Tampa, Florida, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +3 more locations

TERMINATEDPhase 1/2< 1 mile

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

NCT02709889

The primary objective of this study is to assess the safety and tolerability of rovalpituzumab tesirine in subjects with specific delta-like protein 3-expressing advanced solid tumors.

Malignant MelanomaMedullary Thyroid CancerGlioblastoma+5 more

AbbVie200 participantsStarted Sep 2016

Gilbert, Arizona, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +27 more locations

A Survivorship Care Plan and Embedded Navigation Tool

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Prostate Cancer Trials in Other Cities

Perioperative Post-Prostatectomy Incontinence Home Telehealth Program

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Assessment of VMCore Biopsy Versus Standard of Care Biopsy

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

A Registry for Hereditary Cancer Risk Assessment and Genetic Testing

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach

Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Other Conditions in Atlanta